Interleukin-3, Interleukin-5 and GM-CSF signaling (Homo sapiens)

From WikiPathways

Revision as of 21:53, 4 March 2011 by MaintBot (Talk | contribs)
Jump to: navigation, search
1, 24015-1735, 3840, 4181828, 2944552141, 722, 2335-3753, 541433, 344135450, 515, 1142, 43329, 1019-2124-263923, 2445-4846, 49923, 273930, 315512, 134-6nucleoplasmcytosolATPGRB2IL5 homodimerHigh affinity binding complex dimers of cytokine receptors using Bc, activated JAK2High affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2, p-(Y593,628)-Bc:p(427,349,350)-SHC1IL3ADPB-cell linker proteinIL5RACRKTyrosine kinases that phosphorylate the Common beta chainJAK2FYN-like kinases:p(Y731)-CBL:GRB2:Ubiquitinated p85-containing Class 1A PI3KsGTPH-Ras-GTPRAPGEF1p(Y700,731,774)-CBLSHC1ADPB-cell linker protein:p(Y700,731,774)-CBLATPADPp-STAT5High affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2, p(S589)-BcSTAT5ADP14-3-3 zetaGM-CSF:GM-CSF receptor alpha subunit:Common beta chain:JAK2GM-CSF receptor alpha subunitGM-CSF:GM-CSF receptor alpha subunitCBLGRB2:SOS1FYN-like kinasesHigh affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2, p(Y593,628)-Bc:SHC1Interleukin receptor complexes with activated Shc:GRB2:p-GAB2p85-containing Class 1A PI3KsIL5 homodimer:IL5RA:Common beta chain:JAK2IL3RA:IL3:Common beta chain:JAK2High affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2, p(S589)-Bc:14-3-3 zetacAMP-dependent protein kinase, beta-catalytic subunitHigh affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2, p(Y593,628)-Bcp(Y700,731,774)-CBL:CRK:RAPGEF1Interleukin receptor complexes with activated SHC1:SHIP:GRB2IL5p(Y700,731,774)-CBL:VAV1High affinity binding complex dimers of cytokine receptors using Bc, activated JAK2:p-STAT5Interleukin receptor complexes with activated SHC1High affinity binding complexes of interleukin receptors using the Common beta chainFYN-like kinases:CBL:GRB2:p85-containing Class 1A PI3KsInterleukin receptor compexes with activated Shc:GRB2:GAB2p(Y700,731,774)-CBL:CRKSHIP1,2High affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2Granulocyte-macrophage colony-stimulating factorHigh affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2, p(S589)-Bc:14-3-3 zeta:p85-containing Class 1A PI3KsIL3:IL3RAHigh affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2,p(Y593,628)-Bc:SHP1, SHP2K48-polyubiquitinSHP2:GRB2Interleukin receptor complexes with activated SHC1:SHIP1IL3RAInterleukin receptor complexes with activated SHC1:GRB2:SOS1ATPATPInterleukin receptor complexes with activated SHC1:SHIP1,2High affinity binding complex dimers of cytokine receptors using Bc, inactive JAK2,p(Y593)-Bc:SHP1, SHP2GRB2:GAB2TEC:VAV1SHP-2/SHP-1STAT5 dimersTECFYN-like kinases:p(Y731)-CBL:GRB2:p85-containing Class 1A PI3KsADPATPIL5 homodimer:IL5RAH-Ras-GDPVAV1Phospho (2 sites) RAF1Ras:GTP:Phospho (2 sites) RAF1STAT5 dimersGM-CSF/IL-3/IL-5 receptor common beta chainInterleukin receptor complexes with activated Shc:GRB2:p-GAB2:p85-containing Class 1 PI3KsHigh affinity binding complex dimers of cytokine receptors using Bc. activated JAK2:STAT5Common beta chain:JAK2GDPSHP2


Description

The Interleukin-3 (IL-3), IL-5 and Granulocyte-macrophage colony stimulating factor (GM-CSF) receptors form a family of heterodimeric receptors that have specific alpha chains but share a common beta subunit, often referred to as the common beta (Bc). Both subunits contain extracellular conserved motifs typical of the cytokine receptor superfamily. The cytoplasmic domains have limited similarity with other cytokine receptors and lack detectable catalytic domains such as tyrosine kinase domains.

IL-3 is a 20-26 kDa product of CD4+ T cells that acts on the most immature marrow progenitors. IL-3 is capable of inducing the growth and differentiation of multi-potential hematopoietic stem cells, neutrophils, eosinophils, megakaryocytes, macrophages, lymphoid and erythroid cells. IL-3 has been used to support the proliferation of murine cell lines with properties of multi-potential progenitors, immature myeloid as well as T and pre-B lymphoid cells (Miyajima et al. 1992). IL-5 is a hematopoietic growth factor responsible for the maturation and differentiation of eosinophils. It was originally defined as a T-cell-derived cytokine that triggers activated B cells for terminal differentiation into antibody-secreting plasma cells. It also promotes the generation of cytotoxic T-cells from thymocytes. IL-5 induces the expression of IL-2 receptors (Kouro & Takatsu 2009). GM-CSF is produced by cells (T-lymphocytes, tissue macrophages, endothelial cells, mast cells) found at sites of inflammatory responses. It stimulates the growth and development of progenitors of granulocytes and macrophages, and the production and maturation of dendritic cells. It stimulates myeloblast and monoblast differentiation, synergises with Epo in the proliferation of erythroid and megakaryocytic progenitor cells, acts as an autocrine mediator of growth for some types of acute myeloid leukemia, is a strong chemoattractant for neutrophils and eosinophils. It enhances the activity of neutrophils and macrophages. Under steady-state conditions GM-CSF is not essential for the production of myeloid cells, but it is required for the proper development of alveolar macrophages, otherwise, pulmonary alvelolar proteinosis (PAP) develops. A growing body of evidence suggests that GM-CSF plays a key role in emergency hematopoiesis (predominantly myelopoiesis) in response to infection, including the production of granulocytes and macrophages in the bone marrow and their maintenance, survival, and functional activation at sites of injury or insult (Hercus et al. 2009).

All three receptors have alpha chains that bind their specific ligands with low affinity (de Groot et al. 1998). Bc then associates with the alpha chain forming a high affinity receptor (Geijsen et al. 2001), though the in vivo receptor is likely be a higher order multimer as recently demonstrated for the GM-CSF receptor (Hansen et al. 2008).

The receptor chains lack intrinsic kinase activity, instead they interact with and activate signaling kinases, notably Janus Kinase 2 (JAK2). These phosphorylate the common beta subunit, allowing recruitment of signaling molecules such as Shc, the phosphatidylinositol 3-kinases (PI3Ks), and the Signal Transducers and Activators of Transcription (STATs). The cytoplasmic domain of Bc has two distinct functional domains: the membrane proximal region mediates the induction of proliferation-associated genes such as c-myc, pim-1 and oncostatin M. This region binds multiple signal-transducing proteins including JAK2 (Quelle et al. 1994), STATs, c-Src and PI3 kinase (Rao and Mufson, 1995). The membrane distal domain is required for cytokine-induced growth inhibition and is necessary for the viability of hematopoietic cells (Inhorn et al. 1995). This region interacts with signal-transducing proteins such as Shc (Inhorn et al. 1995) and SHP and mediates the transcriptional activation of c-fos, c-jun, c-Raf and p70S6K (Reddy et al. 2000).



Figure reproduced by permission from Macmillan Publishers Ltd: Leukemia, WL Blalock et al. 13:1109-1166, copyright 1999. Note that residue numbering in this diagram refers to the mature Common beta chain with signal peptide removed.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Marengère LE, Mirtsos C, Kozieradzki I, Veillette A, Mak TW, Penninger JM.; ''Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells.''; PubMed Europe PMC Scholia
  2. Kyriakis JM, Avruch J.; ''Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.''; PubMed Europe PMC Scholia
  3. Sakamaki K, Miyajima I, Kitamura T, Miyajima A.; ''Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation.''; PubMed Europe PMC Scholia
  4. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, Schlessinger J, Pawson T.; ''Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.''; PubMed Europe PMC Scholia
  5. Guthridge MA, Stomski FC, Thomas D, Woodcock JM, Bagley CJ, Berndt MC, Lopez AF.; ''Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors.''; PubMed Europe PMC Scholia
  6. Stomski FC, Dottore M, Winnall W, Guthridge MA, Woodcock J, Bagley CJ, Thomas DT, Andrews RK, Berndt MC, Lopez AF.; ''Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF.''; PubMed Europe PMC Scholia
  7. Gaffen SL, Lai SY, Ha M, Liu X, Hennighausen L, Greene WC, Goldsmith MA.; ''Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity.''; PubMed Europe PMC Scholia
  8. Wellbrock C, Karasarides M, Marais R.; ''The RAF proteins take centre stage.''; PubMed Europe PMC Scholia
  9. Stomski FC, Woodcock JM, Zacharakis B, Bagley CJ, Sun Q, Lopez AF.; ''Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors.''; PubMed Europe PMC Scholia
  10. Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AE, Graber P, Wells TN.; ''A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5.''; PubMed Europe PMC Scholia
  11. Roberts PJ, Der CJ.; ''Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.''; PubMed Europe PMC Scholia
  12. Gu H, Pratt JC, Burakoff SJ, Neel BG.; ''Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation.''; PubMed Europe PMC Scholia
  13. Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC.; ''Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.''; PubMed Europe PMC Scholia
  14. Harkiolaki M, Tsirka T, Lewitzky M, Simister PC, Joshi D, Bird LE, Jones EY, O'Reilly N, Feller SM.; ''Distinct binding modes of two epitopes in Gab2 that interact with the SH3C domain of Grb2.''; PubMed Europe PMC Scholia
  15. Roskoski R.; ''ERK1/2 MAP kinases: structure, function, and regulation.''; PubMed Europe PMC Scholia
  16. Wickrema A, Uddin S, Sharma A, Chen F, Alsayed Y, Ahmad S, Sawyer ST, Krystal G, Yi T, Nishada K, Hibi M, Hirano T, Platanias LC.; ''Engagement of Gab1 and Gab2 in erythropoietin signaling.''; PubMed Europe PMC Scholia
  17. Hunter S, Koch BL, Anderson SM.; ''Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase.''; PubMed Europe PMC Scholia
  18. Odai H, Sasaki K, Iwamatsu A, Nakamoto T, Ueno H, Yamagata T, Mitani K, Yazaki Y, Hirai H.; ''Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.''; PubMed Europe PMC Scholia
  19. McKay MM, Morrison DK.; ''Integrating signals from RTKs to ERK/MAPK.''; PubMed Europe PMC Scholia
  20. Devos R, Plaetinck G, Van der Heyden J, Cornelis S, Vandekerckhove J, Fiers W, Tavernier J.; ''Molecular basis of a high affinity murine interleukin-5 receptor.''; PubMed Europe PMC Scholia
  21. Rosenthal LA, Winestock KD, Finbloom DS.; ''IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.''; PubMed Europe PMC Scholia
  22. Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG.; ''Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.''; PubMed Europe PMC Scholia
  23. Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H.; ''Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G.''; PubMed Europe PMC Scholia
  24. Turjanski AG, Vaqué JP, Gutkind JS.; ''MAP kinases and the control of nuclear events.''; PubMed Europe PMC Scholia
  25. Duronio V, Clark-Lewis I, Federsppiel B, Wieler JS, Schrader JW.; ''Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor.''; PubMed Europe PMC Scholia
  26. Feshchenko EA, Langdon WY, Tsygankov AY.; ''Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells.''; PubMed Europe PMC Scholia
  27. Gotoh N, Tojo A, Shibuya M.; ''A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3.''; PubMed Europe PMC Scholia
  28. Plotnikov A, Zehorai E, Procaccia S, Seger R.; ''The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation.''; PubMed Europe PMC Scholia
  29. Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA.; ''Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs.''; PubMed Europe PMC Scholia
  30. Brockdorff JL, Gu H, Mustelin T, Kaltoft K, Geisler C, Röpke C, Ødum N.; ''Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a.''; PubMed Europe PMC Scholia
  31. Anderson SM, Burton EA, Koch BL.; ''Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase.''; PubMed Europe PMC Scholia
  32. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA.; ''Mutations of the BRAF gene in human cancer.''; PubMed Europe PMC Scholia
  33. Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y, Hirai H.; ''The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells.''; PubMed Europe PMC Scholia
  34. Behrmann I, Janzen C, Gerhartz C, Schmitz-Van de Leur H, Hermanns H, Heesel B, Graeve L, Horn F, Tavernier J, Heinrich PC.; ''A single STAT recruitment module in a chimeric cytokine receptor complex is sufficient for STAT activation.''; PubMed Europe PMC Scholia
  35. Miura-Shimura Y, Duan L, Rao NL, Reddi AL, Shimura H, Rottapel R, Druker BJ, Tsygankov A, Band V, Band H.; ''Cbl-mediated ubiquitinylation and negative regulation of Vav.''; PubMed Europe PMC Scholia
  36. Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A.; ''Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor.''; PubMed Europe PMC Scholia
  37. Dufour C, Guenou H, Kaabeche K, Bouvard D, Sanjay A, Marie PJ.; ''FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival.''; PubMed Europe PMC Scholia
  38. Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D.; ''Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.''; PubMed Europe PMC Scholia
  39. Dorsch M, Hock H, Diamantstein T.; ''Tyrosine phosphorylation of Shc is induced by IL-3, IL-5 and GM-CSF.''; PubMed Europe PMC Scholia
  40. Pratt JC, Weiss M, Sieff CA, Shoelson SE, Burakoff SJ, Ravichandran KS.; ''Evidence for a physical association between the Shc-PTB domain and the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor.''; PubMed Europe PMC Scholia
  41. Fukumoto T, Kubota Y, Kitanaka A, Yamaoka G, Ohara-Waki F, Imataki O, Ohnishi H, Ishida T, Tanaka T.; ''Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.''; PubMed Europe PMC Scholia
  42. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G.; ''A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.''; PubMed Europe PMC Scholia
  43. Harmer SL, DeFranco AL.; ''The src homology domain 2-containing inositol phosphatase SHIP forms a ternary complex with Shc and Grb2 in antigen receptor-stimulated B lymphocytes.''; PubMed Europe PMC Scholia
  44. Bone H, Dechert U, Jirik F, Schrader JW, Welham MJ.; ''SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates.''; PubMed Europe PMC Scholia
  45. Lamkin TD, Walk SF, Liu L, Damen JE, Krystal G, Ravichandran KS.; ''Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP.''; PubMed Europe PMC Scholia
  46. Ye SK, Agata Y, Lee HC, Kurooka H, Kitamura T, Shimizu A, Honjo T, Ikuta K.; ''The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation.''; PubMed Europe PMC Scholia
  47. Kline JB, Moore DJ, Clevenger CV.; ''Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site.''; PubMed Europe PMC Scholia
  48. Orban PC, Levings MK, Schrader JW.; ''Heterodimerization of the alpha and beta chains of the interleukin-3 (IL-3) receptor is necessary and sufficient for IL-3-induced mitogenesis.''; PubMed Europe PMC Scholia
  49. Guthridge MA, Stomski FC, Barry EF, Winnall W, Woodcock JM, McClure BJ, Dottore M, Berndt MC, Lopez AF.; ''Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival.''; PubMed Europe PMC Scholia
  50. Flores-Morales A, Pircher TJ, Silvennoinen O, Gustafsson JA, Sanchez-Gomez M, Norstedt G, Haldosén LA, Wood TJ.; ''In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.''; PubMed Europe PMC Scholia
  51. Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, Ramshaw H, Woodcock JM, Xu Y, Guthridge M, McKinstry WJ, Lopez AF, Parker MW.; ''The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation.''; PubMed Europe PMC Scholia
  52. Roskoski R.; ''RAF protein-serine/threonine kinases: structure and regulation.''; PubMed Europe PMC Scholia
  53. Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN.; ''JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.''; PubMed Europe PMC Scholia
  54. Song H, Zhang J, Chiang YJ, Siraganian RP, Hodes RJ.; ''Redundancy in B cell developmental pathways: c-Cbl inactivation rescues early B cell development through a B cell linker protein-independent pathway.''; PubMed Europe PMC Scholia
  55. Kitamura T, Sato N, Arai K, Miyajima A.; ''Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors.''; PubMed Europe PMC Scholia
  56. Gearing DP, King JA, Gough NM, Nicola NA.; ''Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.''; PubMed Europe PMC Scholia
  57. Park RK, Kyono WT, Liu Y, Durden DL.; ''CBL-GRB2 interaction in myeloid immunoreceptor tyrosine activation motif signaling.''; PubMed Europe PMC Scholia
  58. Brown MD, Sacks DB.; ''Protein scaffolds in MAP kinase signalling.''; PubMed Europe PMC Scholia
  59. Sorensen P, Mui AL, Krystal G.; ''Interleukin-3 stimulates the tyrosine phosphorylation of the 140-kilodalton interleukin-3 receptor.''; PubMed Europe PMC Scholia
  60. Cargnello M, Roux PP.; ''Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.''; PubMed Europe PMC Scholia
  61. Stanton ML, Brodeur PH.; ''Stat5 mediates the IL-7-induced accessibility of a representative D-Distal VH gene.''; PubMed Europe PMC Scholia
  62. Andoniou CE, Thien CB, Langdon WY.; ''The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.''; PubMed Europe PMC Scholia
  63. Gu H, Maeda H, Moon JJ, Lord JD, Yoakim M, Nelson BH, Neel BG.; ''New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.''; PubMed Europe PMC Scholia
  64. Fang D, Liu YC.; ''Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.''; PubMed Europe PMC Scholia
  65. Roskoski R.; ''MEK1/2 dual-specificity protein kinases: structure and regulation.''; PubMed Europe PMC Scholia
  66. Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN.; ''Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.''; PubMed Europe PMC Scholia
  67. Cseh B, Doma E, Baccarini M.; ''"RAF" neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway.''; PubMed Europe PMC Scholia
  68. Cantwell-Dorris ER, O'Leary JJ, Sheils OM.; ''BRAFV600E: implications for carcinogenesis and molecular therapy.''; PubMed Europe PMC Scholia
  69. Ravichandran KS, Burakoff SJ.; ''The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation.''; PubMed Europe PMC Scholia
  70. Ingham RJ, Okada H, Dang-Lawson M, Dinglasan J, van Der Geer P, Kurosaki T, Gold MR.; ''Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.''; PubMed Europe PMC Scholia
  71. Machide M, Mano H, Todokoro K.; ''Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114742view16:22, 25 January 2021ReactomeTeamReactome version 75
113186view11:25, 2 November 2020ReactomeTeamReactome version 74
112414view15:35, 9 October 2020ReactomeTeamReactome version 73
101318view11:20, 1 November 2018ReactomeTeamreactome version 66
100855view20:52, 31 October 2018ReactomeTeamreactome version 65
100396view19:26, 31 October 2018ReactomeTeamreactome version 64
99944view16:11, 31 October 2018ReactomeTeamreactome version 63
99500view14:44, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99148view12:41, 31 October 2018ReactomeTeamreactome version 62
93872view13:42, 16 August 2017ReactomeTeamreactome version 61
93439view11:23, 9 August 2017ReactomeTeamreactome version 61
86530view09:20, 11 July 2016ReactomeTeamreactome version 56
83413view11:10, 18 November 2015ReactomeTeamVersion54
81612view13:09, 21 August 2015ReactomeTeamVersion53
77073view08:37, 17 July 2014ReactomeTeamFixed remaining interactions
76778view12:14, 16 July 2014ReactomeTeamFixed remaining interactions
76100view10:16, 11 June 2014ReactomeTeamRe-fixing comment source
75812view11:35, 10 June 2014ReactomeTeamReactome 48 Update
75162view14:11, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74809view08:54, 30 April 2014ReactomeTeamReactome46
44874view10:01, 6 October 2011MartijnVanIerselOntology Term : 'Interleukin mediated signaling pathway' added !
42059view21:53, 4 March 2011MaintBotAutomatic update
39866view05:53, 21 January 2011MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
14-3-3

zeta

ProteinP63104 (UniProt)
ADP Metabolite16761 (ChEBI)
ATP Metabolite15422 (ChEBI)
B-cell linker

protein

ProteinQ8WV28 (UniProt)
B-cell linker protein:p

(Y700,731,774)-CBL

ComplexREACT_24555 (Reactome)
CBL ProteinP22681 (UniProt)
CRK ProteinREACT_24469 (Reactome)
Common beta

chain:JAK2

ComplexREACT_24165 (Reactome)
FYN-like kinases ProteinREACT_24391 (Reactome)
FYN-like kinases:

CBL:GRB2:p85- containing Class 1A PI3Ks

ComplexREACT_24661 (Reactome)
FYN-like kinases:p

(Y731)-CBL:GRB2: Ubiquitinated p85- containing Class 1A PI3Ks

ComplexREACT_24386 (Reactome)
FYN-like kinases:p

(Y731)-CBL:GRB2: p85-containing Class 1A PI3Ks

ComplexREACT_24228 (Reactome)
GDP Metabolite17552 (ChEBI)
GM-CSF receptor

alpha subunit

ProteinP15509 (UniProt)
GM-CSF/IL-3/IL-5

receptor common beta chain

ProteinP32927 (UniProt)
GM-CSF:GM-CSF

receptor alpha subunit

ComplexREACT_24102 (Reactome)
GM-CSF:GM-CSF

receptor alpha subunit:Common beta chain:JAK2

ComplexREACT_24858 (Reactome)
GRB2 ProteinP62993-1 (UniProt)
GRB2:GAB2 ComplexREACT_24714 (Reactome)
GRB2:SOS1 ComplexREACT_4435 (Reactome)
GTP Metabolite15996 (ChEBI)
Granulocyte-

macrophage colony- stimulating factor

ProteinP04141 (UniProt)
H-Ras-GDP ComplexREACT_24031 (Reactome)
H-Ras-GTP ComplexREACT_24217 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, activated JAK2

ComplexREACT_24626 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, activated JAK2:p-STAT5

ComplexREACT_24628 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2, p(S589)-Bc

ComplexREACT_24222 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2, p(S589)-Bc:14- 3-3 zeta

ComplexREACT_24266 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2, p(Y593,628)- Bc:SHC1

ComplexREACT_24884 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2, p-(Y593,628)- Bc:p(427,349,350)- SHC1

ComplexREACT_24225 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2,p(Y593)-Bc: SHP1, SHP2

ComplexREACT_24560 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2,p(Y593,628)-Bc: SHP1, SHP2

ComplexREACT_24887 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2

ComplexREACT_24738 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2, p(Y593,628)-Bc

ComplexREACT_24147 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc. activated JAK2:STAT5

ComplexREACT_24047 (Reactome)
High affinity binding

complex dimers of cytokine receptors using Bc, inactive JAK2, p (S589)-Bc:14-3-3 zeta: p85-containing Class 1A PI3Ks

ComplexREACT_24243 (Reactome)
High affinity binding

complexes of interleukin receptors using the Common beta chain

ComplexREACT_24474 (Reactome)
IL3 ProteinP08700 (UniProt)
IL3:IL3RA ComplexREACT_24866 (Reactome)
IL3RA ProteinP26951 (UniProt)
IL3RA:IL3:Common

beta chain:JAK2

ComplexREACT_24229 (Reactome)
IL5 ProteinP05113 (UniProt)
IL5 homodimer ComplexREACT_24473 (Reactome)
IL5 homodimer:

IL5RA

ComplexREACT_24270 (Reactome)
IL5 homodimer:

IL5RA:Common beta chain:JAK2

ComplexREACT_24214 (Reactome)
IL5RA ProteinQ01344 (UniProt)
Interleukin receptor

compexes with activated Shc:GRB2:GAB2

ComplexREACT_24494 (Reactome)
Interleukin receptor

complexes with activated SHC1

ComplexREACT_24730 (Reactome)
Interleukin receptor

complexes with activated SHC1: GRB2:SOS1

ComplexREACT_24582 (Reactome)
Interleukin receptor

complexes with activated SHC1: SHIP1,2

ComplexREACT_24093 (Reactome)
Interleukin receptor

complexes with activated SHC1:SHIP1

ComplexREACT_24554 (Reactome)
Interleukin receptor

complexes with activated SHC1:SHIP: GRB2

ComplexREACT_24297 (Reactome)
Interleukin receptor

complexes with activated Shc:GRB2: p-GAB2:p85- containing Class 1 PI3Ks

ComplexREACT_24797 (Reactome)
Interleukin receptor

complexes with activated Shc:GRB2:p-GAB2

ComplexREACT_24779 (Reactome)
JAK2 ProteinO60674 (UniProt)
K48-polyubiquitin UnknownREACT_24769 (Reactome)
Phospho (2 sites)

RAF1

ProteinP04049 (UniProt)
RAPGEF1 ProteinQ13905 (UniProt)
Ras:GTP:Phospho (2

sites) RAF1

ComplexREACT_24177 (Reactome)
SHC1 ProteinP29353 (UniProt)
SHIP1,2 ProteinREACT_24095 (Reactome)
SHP-2/SHP-1 ProteinREACT_20250 (Reactome)
SHP2 ProteinQ06124 (UniProt)
SHP2:GRB2 ComplexREACT_24568 (Reactome)
STAT5 ProteinREACT_24211 (Reactome)
STAT5 dimers UnknownREACT_24109 (Reactome)
STAT5 dimers UnknownREACT_24289 (Reactome)
TEC ProteinP42680 (UniProt)
TEC:VAV1 ComplexREACT_24039 (Reactome)
Tyrosine kinases that

phosphorylate the Common beta chain

ComplexREACT_24291 (Reactome)
VAV1 ProteinP15498 (UniProt)
cAMP-dependent

protein kinase, beta- catalytic subunit

ProteinP22694 (UniProt)
p(Y700,731,774)-

CBL

ProteinP22681 (UniProt)
p(Y700,731,774)-

CBL:CRK

ComplexREACT_24612 (Reactome)
p(Y700,731,774)-

CBL:CRK:RAPGEF1

ComplexREACT_24589 (Reactome)
p(Y700,731,774)-

CBL:VAV1

ComplexREACT_24764 (Reactome)
p-STAT5 UnknownREACT_24299 (Reactome)
p85-containing

Class 1A PI3Ks

ComplexREACT_24162 (Reactome) This set represents Class 1A PI3Ks including all three genes that can give rise to the five isoforms of the regulatory subunit. Note that the p85 alpha form is almost always the form used experimentally (especially where p85-Abs are used) - the other forms are rarely shown experimentally. Also note it may not be the most relevant physiologically in some cell types (e.g. T cells).

Annotated Interactions

No annotated interactions

Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP1840"
Personal tools